BRIEF-AstraZeneca, Bristol resubmit dapagliflozin in U.S.
July 25 (Reuters) - AstraZeneca PLC : * Astrazeneca Plc and Bristol-Myers Squibb Co say resubmit
dapagliflozin new drug application in the U.S.
- Lost airliner was diverted deliberately: Malaysian PM |
- Exclusive: Radar data suggests missing Malaysia plane deliberately flown way off course - sources
- Malaysia PM says lost plane's movements indicate a deliberate act
- UPDATE 2-Satellite data shows missing Malaysia plane may have flown thousands of miles-source
- UPDATE 1-Rolls-Royce concurs with Malaysia on missing jet's engine data